Specialty Pharma Journal Specialty, Precision & Technology
Today, the U.S. Food and Drug Administration took another significant diagnostic action during the coronavirus …
Read More »FDA Issues Emergency Use Authorization to Thermo Fisher for its TaqPath COVID-19 Combo Kit
Recent Posts
Pfizer and EMD Serono Terminate Phase 3 Study of Avelumab Plus CRT for Treatment of Head and Neck Cancer
ROCKLAND, Mass. and NEW YORK, March 13, 2020 /PRNewswire/ — EMD Serono, the biopharmaceutical business …
Read More »FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Kidney Disease
INGELHEIM, Germany, and INDIANAPOLIS, Ind.–(BUSINESS WIRE)–The U.S. Food and Drug Administration (FDA) has granted Fast …
Read More »FDA Grants Fast Track Designation to Balstilimab and Zalifrelimab for Treatment of Advanced Cervical Cancer
LEXINGTON, Mass., March 12, 2020 /PRNewswire/ — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with …
Read More »Thermo Fisher Scientific Signs Agreement with Janssen to Co-Develop Companion Diagnostic for Cancer
CARLSBAD, Calif., March 12, 2020 /PRNewswire/ — Thermo Fisher Scientific announced today it has signed …
Read More »Preclinical Data Show Tumor Treating Fields Induces Immunogenic Cell Death Resulting in Enhanced Antitumor Efficacy When Combined with Anti-PD-1 Therapy
ST. HELIER, Jersey–(BUSINESS WIRE)–Novocure (NASDAQ: NVCR) announced today that preclinical data on Tumor Treating Fields in combination …
Read More »Phase 3 Study of Cerdiranib and Lynparza Fails to Meet Primary Endpoint in Platinum-Resistant Ovarian Cancer
KENILWORTH, N.J.–(BUSINESS WIRE)–AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and …
Read More »Engage Therapeutics Announces Phase 2b Study of Staccato Alprazolam for Seizure Cessation Meets Primary Endpoint
SUMMIT, N.J., March 12, 2020 (GLOBE NEWSWIRE) — Engage Therapeutics, Inc., a clinical-stage biopharmaceutical company focused …
Read More »FDA Grants Accelerated Approval for Opdivo Plus Yervoy for Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb Company (NYSE: BMY) today announced that Opdivo (nivolumab) 1 mg/kg plus Yervoy (ipilimumab) 3 mg/kg …
Read More »Forty Seven and Rocket Pharmaceuticals Announce Research Collaboration for Fanconi Anemia
MENLO PARK, Calif. and NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) — Forty Seven, Inc. …
Read More »Roche Receives FDA Approval for CINtec PLUS Cytology Test to Aid Clinicians in Improving Cervical Cancer Prevention
Basel, 11 March 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food …
Read More »Janssen Announces FDA Breakthrough Therapy Designation for JNJ-6372 for Treatment of Non-Small Cell Lung Cancer
RARITAN, N.J., March 10, 2020 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson …
Read More »Phase 3 Study of Ninlaro Plus Lenalidomide and Dexamethasone Fails to Meet Primary Endpoint in Newly Diagnosed Multiple Myeloma Patients
CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results …
Read More »CVS Pharmacy to Acquire Schnuck Markets Retail and Specialty Pharmacy Businesses
WOONSOCKET, R.I., March 10, 2020 /PRNewswire/ — CVS Pharmacy, Inc., a subsidiary of CVS Health …
Read More »Daré Bioscience Receives FDA Fast Track Designation for DARE-BV1 for the Treatment of Bacterial Vaginosis
SAN DIEGO, March 10, 2020 (GLOBE NEWSWIRE) — Daré Bioscience, Inc.(NASDAQ: DARE), a leader in women’s health …
Read More »